Scientists show that drugs targeting tumour metabolism will not stop Natural Killer cells

Source: eCancer, June 2018

Scientists have just made an important discovery as to how cancer-targeting ‘Natural Killer’ (NK) cells are fuelled in the body, which has significant implications for related therapies. They found that glutamine – vital for making the energy that fuels tumour cell growth – is not an important fuel for making energy in NK cells, which instead primarily use glucose. As a result the door is now open to targeting glutamine metabolism in tumour cells, as any drugs that do this will not hinder our cancer-killing NK cells.

The scientists, led by Ussher Assistant Professor in Immunometabolism at Trinity College Dublin, Dr David Finlay, have just published their findings in leading journal Nature Communications.

read the original full article